Insights

Universal DX (UDX) Closes Series B Funding for Clinical Trials on Colorectal Cancer Screening Blood Test, Signal-C®

Choate represented Universal DX (UDX) in IP diligence for its Series B funding round, which will advance the clinical trial of Signal-C, UDX’s colorectal cancer screening blood test, which is on track to enroll 15,000 patients across 100 sites.

Choate Receives High Rankings from Managing IP 2024

Managing IP’s 2024 rankings of firms for patent litigation and protection work recognizes eight attorneys and Choate regionally and nationally for its work in the areas of patent prosecution and patent disputes.

The White House Issues Executive Order on AI

On October 30, 2023, President Biden issued an Executive Order (EO) that directs the National Institute of Standards and Technology (NIST) to develop standards for red-team testing of AI models, that is, adversarial testing for software risks and vulnerabilities.

Choate Receives High Rankings for Patent Work from Managing IP 2023

Managing IP’s 2023 rankings of firms for patent litigation and protection work recognizes seven attorneys and Choate regionally and nationally for its work in the areas of patent prosecution, patent disputes and life sciences.

Managing IP Names Seven Choate Attorneys "IP Stars"

Managing IP recognizes seven Choate attorneys – Michael S. Bunis, Robert S. Frank Jr., Dr. William R. Haulbrook, Dr. Brenda Herschbach Jarrell, Dr. Charles Lyon, Eric J. Marandett, Dr. Rolando Medina – in its 2022 guide of “IP Stars.”

Immuneering Corporation Goes Public with $112M IPO

Choate assisted Immuneering Corporation with handling its platform IP in its $112.5M IPO. A portion of the proceeds from the IPO will be used to bring Immuneering’s lead candidate, a dual-MEK inhibitor dubbed IMM-1-104, into the clinic for advanced solid tumors in patients harboring RAS mutations.

Choate Partners Ranked as IP Stars by Managing IP

Managing IP recently recognized six Choate partners - Robert S. Frank Jr., Dr. William R. Haulbrook, Dr. Brenda Herschbach Jarrell, Dr. Charles Lyon, Eric J. Marandett, and Dr. Rolando Medina – in its 2021 guide of “IP Stars.”

Choate Partners Named IP Stars by Managing IP

Six partners – Robert S. Frank Jr., Dr. William R. Haulbrook, Dr. Brenda Herschbach Jarrell, Dr. Charles Lyon, Eric J. Marandett, and Dr. Rolando Medina– have been included in the Managing Intellectual Property Magazine global 2020 rankings of “IP Stars.”

Progenics Pharmaceuticals Reaches Agreement with FUJIFILM Toyama Chemical Co.

Choate advised Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and artificial intelligence to find, fight, and follow cancer, and EXINI, a wholly owned subsidiary of Progenics, in its transfer agreement with FUJIFILM Toyama Chemical Co, Ltd. (FFTC) for the rights to Progenics’ Automated Bone Scan Index (aBSI) product in Japan for use under the name BONENAVI. BONENAVI has been licensed to FFTC for use in Japan since 2011.